Crescita Therapeutics Inc (CTX) — Cash Flow Reinvestment Rate
Crescita Therapeutics Inc (CTX) has a Cash Flow Reinvestment Rate of 1.74x as of December 2025, reinvesting CA$724.00K (capex CA$724.00K ) from operating cash flow of CA$416.00K. See CTX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Crescita Therapeutics Inc Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Crescita Therapeutics Inc across 5 annual periods. For the full cash flow conversion analysis, see Crescita Therapeutics Inc (CTX) cash conversion ratio.
Annual Cash Flow Reinvestment Rate for Crescita Therapeutics Inc (2019–2025)
Year-by-year capital reinvestment analysis for Crescita Therapeutics Inc. See Crescita Therapeutics Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CAD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | CA$333.00K | CA$1.07 Million | CA$333.00K | ▼ -73.6% |
| 2024 | 1.18x | CA$3.20 Million | CA$2.73 Million | CA$1.19 Million | ▲ +817.6% |
| 2023 | 0.13x | CA$266.00K | CA$2.08 Million | CA$133.00K | ▲ +508.9% |
| 2020 | 0.02x | CA$118.00K | CA$5.61 Million | CA$59.00K | ▼ -74.0% |
| 2019 | 0.08x | CA$430.00K | CA$5.31 Million | CA$215.00K | — |